viqualine

Uses your system voice; voice and rate in settings.

Q7933523Snapshot

≈ 1 min read

Names in other languages

  • Englishviqualine
  • Portuguêsviqualina
  • Tiếng Việtviqualine
  • فارسیویکوالین
  • Русскийвиквалин
  • shvikvalin
  • Српскиvikvalin
  • 日本語ビクアリン

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Viqualine (INN; developmental code PK-5078) is an antidepressant and anxiolytic drug that was never marketed. It acts as a potent and selective serotonin releasing agent (SRA) and serotonin reuptake inhibitor (SRI) similarly to para-chloroamphetamine (PCA). In addition, viqualine displaces diazepam from the GABA A receptor and produces benzodiazepine-like effects, indicating that it is also a positive allosteric modulator of the benzodiazepine site of the GABA A receptor. The drug has mainly been researched as a potential treatment for alcoholism.

Viqualine (INN; developmental code PK-5078) is an antidepressant and anxiolytic drug that was never marketed. It acts as a potent and selective serotonin releasing agent (SRA) and serotonin reuptake inhibitor (SRI) similarly to para-chloroamphetamine (PCA). In addition, viqualine displaces diazepam from the GABA A receptor and produces benzodiazepine-like effects, indicating that it is also a positive allosteric modulator of the benzodiazepine site of the GABA A receptor. The drug has mainly been researched as a potential treatment for alcoholism.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1340893870 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.